Cancer-associated FBXW7 mutations are most frequent in T cell acute lymphoblastic leukemia (T-ALL), followed by precursor T cell lymphoblastic lymphoma (T-LBL), endometrial carcinoma, small intestine carcinoma, and large intestine carcinoma. Here, FBXW7 is linked to cancer.